CYP2E1 has been proposed to play a role in the development of PD due to its capability to be induced, its ability to metabolize several xenobiotics that are able to cross the blood–brain barrier, and the high level of ROS production during its metabolic reactions [52,53,54]. Here, CYP2E1 is linked to Parkinson disease.